A disintegrin and metalloproteinase 12 (ADAM12) is closely associated with tumor development or prognostic parameters [10–12], is highly expressed in a variety of cancers (lung [13, 14], breast [15–18], bladder [19], liver [20], etc.), and has potential as a tumor diagnostic and prognostic marker [21, 22], according to an increasing number of studies. The gene discussed is ADAM12; the disease is neoplasm.